個股熱度排行 | 11月14日港股收盤
根據uSMART輿情監測數據，14日港股交易時段，市場關注指數最高的5只股票是香港交易所、招商銀行、名創優品、華虹半導體、康希諾生物。
11月14日—港股關注排行TOP5
香港交易所
關注度第一爲香港交易所，該股今日收盤上漲2.53%，報於291.80港元。近5個交易日累計上漲12.40%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
瑞信料港股第四季日均成交升至1,030億元 港交所評級「跑贏大市」
香港交易所反覆升4.7% 瑞信上調港股Q4日均成交額預測
招商銀行
關注度第二爲招商銀行，該股今日收盤上漲7.47%，報於35.95港元。近5個交易日累計上漲18.65%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
招商銀行AH齊漲 獲美銀大升評級至買入
銀行股普遍走高 招商銀行漲9.42%
名創優品
關注度第三爲名創優品，該股今日收盤上漲3.05%，報於13.50港元。近5個交易日累計上漲5.47%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
名創優品第一季度股東應佔溢利4.12億元 同比增加170.74%
名創優品2023財年首季營收27.7億元，毛利淨利創歷史新高
華虹半導體
關注度第四爲華虹半導體，該股今日收盤上漲6.58%，報於25.90港元。近5個交易日累計上漲12.61%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
國金證券維持華虹半導體“買入”評級 指產能滿載回A拉動估值
國金證券：維持華虹半導體“買入”評級 產能滿載及回A上市拉動估值
康希諾生物
關注度第五爲康希諾生物，該股今日收盤上漲12.30%，報於121.40港元。近5個交易日累計上漲3.23%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
康希諾生物吸入用新冠疫苗在浙江11個城市陸續開啓接種
疫苗出海！康希諾生物H股22日漲超近2倍 機構看好海外市場表現
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
